-
-
-
-
-
-
-
Qualigen Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel
-
-
-
-
-
-
-
Qualigen Therapeutics (QLGN) CEO Issues Letter to Shareholders
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

